Evergreen Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Evergreen Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$361K	Sell	10,668 -4,261	-29%	-$142K	0.01%	1101
2026 Q1	$450K	Buy	14,929 +4,364	+41%	+$140K	0.01%	858
2025 Q4	$330K	Buy	+10,565	New	+$260K	0.01%	981
2015 Q1	–	Sell	-56,442	Closed	-$3.03M	–	110
2014 Q4	$3.03M	Sell	56,442 -300	-0.5%	-$16.7K	0.6%	62
2014 Q3	$3.05M	Buy	56,742 +810	+1%	+$42.9K	0.59%	62
2014 Q2	$2.93M	Buy	55,932 +460	+0.8%	+$23.5K	0.58%	63
2014 Q1	$2.93M	Sell	55,472 -285	-0.5%	-$13.2K	0.59%	60
2013 Q4	$2.23M	Buy	55,757 +1,050	+2%	+$41.3K	0.4%	75
2013 Q3	$2.07M	Buy	54,707 +240	+0.4%	+$9.36K	0.33%	87
2013 Q2	$2.13M	Buy	+54,467	New	+$2.12M	0.33%	87

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Evergreen Capital Management's TEVA Position: Q2 2026 in Review

Evergreen Capital Management reduced its Teva Pharmaceuticals (TEVA) stake by 29% in Q2 2026, selling an estimated $142K and leaving 10,668 shares worth $361K. The position accounts for 0.01% of the portfolio, ranked #1101.

Evergreen Capital Management first reported a position in TEVA in Q2 2013 and has held it in 10 quarters since. The position peaked at $3.05M in Q3 2014. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Evergreen Capital Management held 10,668 shares of Teva Pharmaceuticals worth $361K as of Q2 2026.
Evergreen Capital Management sold 4,261 Teva Pharmaceuticals shares in Q2 2026, an estimated $142K.
Teva Pharmaceuticals made up 0.01% of Evergreen Capital Management's portfolio in Q2 2026, its #1101 holding.
Evergreen Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
Evergreen Capital Management's Teva Pharmaceuticals position peaked at $3.05M in Q3 2014.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.